---
title: "WHO updates global catalogue for interpreting tuberculosis drug-resistance mutations"
id: "who-0-2-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance"
canonical_url: "https://medichelpline.com/clinical-feed/who-0-2-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "World Health Organization"
source_url: "https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations"
published_at: "2026-11-10T12:00:00.000Z"
evidence_level: "Departmental update"
license: "CC-BY-NC-4.0 / Informational Use"
---
# WHO updates global catalogue for interpreting tuberculosis drug-resistance mutations
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/who-0-2-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** World Health Organization
- **Source URL:** [Original Journal Publication](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)
- **Published At:** 2026-11-10T12:00:00.000Z
- **Evidence Rating:** Departmental update
## Executive GIST (TL;DR)
- The World Health Organization released an update to its global catalogue for interpreting **tuberculosis** **drug resistance** mutations, according to the WHO news item. - The source page announces the catalogue update but provides no detailed list of specific mutations, drugs, or interpretive classifications in the text available. - The WHO item did not report methodological details for the update, including evidence review process, data sources, or analytic criteria. - The news piece did not specify implementation guidance, clinical workflows, or laboratory integration steps tied to this release. - The WHO page did not include dates, versioning identifiers, or timelines for rollout beyond the publication notice. - The source did not describe stakeholder consultation, public comment periods, or collaborations that informed the update. - The news item did not publish examples of how the updated catalogue should change diagnostic interpretation or patient management. - Outstanding questions from the source include which genes or loci are reclassified, whether new drugs are covered, and how national TB programmes should operationalize changes. - Readers seeking mutation lists, technical annexes, or downloadable datasets must consult WHO product links or contact WHO directly, because the posted news text did not include those materials. - The WHO announcement confirms an update occurred; it did not, in the available text, provide the substantive technical content of that revision.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations#content) * [ World Health Organization ](https://www.who.int/) [Global](https://www.who.int/) * [Regions](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations) World Health Organization WHO Regional websites * [ Africa ](https://www.afro.who.int/) * [ Americas ](https://www.paho.org/en) * [ South-East Asia ](https://www.who.int/southeastasia) * [ Europe ](https://www.who.int/europe/) * [ Eastern Mediterranean ](http://www.emro.who.int/index.html) * [ Western Pacific ](https://www.who.int/westernpacific/) When autocomplete results are available use up and down arrows to review and enter to select. Select language Select language English العربية 中文 Français Русский Español Português [ World Health Organization ](https://www.who.int/ "Home") [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations) * * [ World Health Organization ](https://www.who.int/) [Global](https://www.who.int/) * [Regions](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations) World Health Organization WHO Regional websites * [ Africa ](https://www.afro.who.int/) * [ Americas ](https://www.paho.org/en) * [ South-East Asia ](https://www.who.int/southeastasia) * [ Europe ](https://www.who.int/europe/) * [ Eastern Mediterranean ](http://www.emro.who.int/index.html) * [ Western Pacific ](https://www.who.int/westernpacific/) * Select language English العربية 中文 Français Русский Español Português * [HomeWorld Health Organization](https://www.who.int/) * [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Health Topics](https://www.who.int/mega-menu/health-topics) * [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[All topics](https://www.who.int/health-topics/) * [All topics](https://www.who.int/health-topics/) * [A](https://www.who.int/health-topics/#A) * [B](https://www.who.int/health-topics/#B) * [C](https://www.who.int/health-topics/#C) * [D](https://www.who.int/health-topics/#D) * [E](https://www.who.int/health-topics/#E) * [F](https://www.who.int/health-topics/#F) * [G](https://www.who.int/health-topics/#G) * [H](https://www.who.int/health-topics/#H) * [I](https://www.who.int/health-topics/#I) * [J](https://www.who.int/health-topics/#J) * [K](https://www.who.int/health-topics/#K) * [L](https://www.who.int/health-topics/#L) * [M](https://www.who.int/health-topics/#M) * [N](https://www.who.int/health-topics/#N) * [O](https://www.who.int/health-topics/#O) * [P](https://www.who.int/health-topics/#P) * [Q](https://www.who.int/health-topics/#Q) * [R](https://www.who.int/health-topics/#R) * [S](https://www.who.int/health-topics/#S) * [T](https://www.who.int/health-topics/#T) * [U](https://www.who.int/health-topics/#U) * [V](https://www.who.int/health-topics/#V) * [W](https://www.who.int/health-topics/#W) * [X](https://www.who.int/health-topics/#X) * [Y](https://www.who.int/health-topics/#Y) * [Z](https://www.who.int/health-topics/#Z) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Resources](https://www.who.int/mega-menu/health-topics/resources) * [Fact sheets](https://www.who.int/mega-menu/health-topics/resources/fact-sheets) * [Facts in pictures](https://www.who.int/mega-menu/health-topics/resources/facts-in-pictures) * [Multimedia](https://www.who.int/mega-menu/health-topics/resources/multimedia) * [Podcasts](https://www.who.int/mega-menu/health-topics/resources/podcasts) * [Publications](https://www.who.int/mega-menu/health-topics/resources/publications) * [Questions and answers](https://www.who.int/mega-menu/health-topics/resources/questions-and-answers) * [Tools and toolkits](https://www.who.int/mega-menu/health-topics/resources/tools-and-toolkits) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Popular](https://www.who.int/mega-menu/health-topics/popular) * [Dengue](https://www.who.int/mega-menu/health-topics/popular/dengue) * [Endometriosis](https://www.who.int/mega-menu/health-topics/popular/endometriosis) * [Excessive heat](https://www.who.int/mega-menu/health-topics/popular/excessive-heat) * [Herpes](https://www.who.int/mega-menu/health-topics/popular/herpes) * [Mental disorders](https://www.who.int/mega-menu/health-topics/popular/mental-disorders) * [Mpox](https://www.who.int/mega-menu/health-topics/popular/mpox) * [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Countries](https://www.who.int/mega-menu/countries) * [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[All countries](https://www.who.int/countries) * [All countries](https://www.who.int/countries) * [A](https://www.who.int/countries/#A) * [B](https://www.who.int/countries/#B) * [C](https://www.who.int/countries/#C) * [D](https://www.who.int/countries/#D) * [E](https://www.who.int/countries/#E) * [F](https://www.who.int/countries/#F) * [G](https://www.who.int/countries/#G) * [H](https://www.who.int/countries/#H) * [I](https://www.who.int/countries/#I) * [J](https://www.who.int/countries/#J) * [K](https://www.who.int/countries/#K) * [L](https://www.who.int/countries/#L) * [M](https://www.who.int/countries/#M) * [N](https://www.who.int/countries/#N) * [O](https://www.who.int/countries/#O) * [P](https://www.who.int/countries/#P) * [Q](https://www.who.int/countries/#Q) * [R](https://www.who.int/countries/#R) * [S](https://www.who.int/countries/#S) * [T](https://www.who.int/countries/#T) * [U](https://www.who.int/countries/#U) * [V](https://www.who.int/countries/#V) * [W](https://www.who.int/countries/#W) * [X](https://www.who.int/countries/#X) * [Y](https://www.who.int/countries/#Y) * [Z](https://www.who.int/countries/#Z) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Regions](https://www.who.int/mega-menu/countries/regions) * [Africa](https://www.who.int/mega-menu/countries/regions/africa) * [Americas](https://www.who.int/mega-menu/countries/regions/americas) * [Europe](https://www.who.int/mega-menu/countries/regions/europe) * [Eastern Mediterranean](https://www.who.int/mega-menu/countries/regions/eastern-mediterranean) * [South-East Asia ](https://www.who.int/mega-menu/countries/regions/south-east-asia) * [Western Pacific](https://www.who.int/mega-menu/countries/regions/western-pacific) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[WHO in countries](https://www.who.int/mega-menu/countries/who-in-countries) * [Data by country](https://www.who.int/mega-menu/countries/who-in-countries/data-by-country) * [Country presence ](https://www.who.int/mega-menu/countries/who-in-countries/country-presence) * [Country cooperation strategies ](https://www.who.int/mega-menu/countries/who-in-countries/country-cooperation-strategies) * [Country office profiles](https://www.who.int/mega-menu/countries/who-in-countries/country-office-profiles) * [Strengthening country offices ](https://www.who.int/mega-menu/countries/who-in-countries/country-strengthening) * [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Newsroom](https://www.who.int/news-room) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Newsroom](https://www.who.int/mega-menu/news/all-news) * [News releases](https://www.who.int/mega-menu/news/all-news/releases) * [Statements](https://www.who.int/mega-menu/news/all-news/statements) * [Campaigns](https://www.who.int/mega-menu/news/all-news/campaigns) * [Events](https://www.who.int/mega-menu/news/all-news/events) * [Feature stories](https://www.who.int/mega-menu/news/all-news/feature-stories) * [Speeches](https://www.who.int/mega-menu/news/all-news/speecheshub) * [Commentaries](https://www.who.int/mega-menu/news/all-news/commentaries) * [Photo library](https://www.who.int/mega-menu/news/all-news/photo-library) * [Headlines](https://www.who.int/news-room/headlines) * [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Emergencies](https://www.who.int/mega-menu/emergencies) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[In focus](https://www.who.int/mega-menu/emergencies/emergencies) * [Cholera ](https://www.who.int/mega-menu/emergencies/emergencies/cholera) * [Ebola disease](https://www.who.int/mega-menu/emergencies/emergencies/ebola-disease) * [Israel and the occupied Palestinian territory](https://www.who.int/mega-menu/emergencies/emergencies/israel-and-occupied-palestinian-territory) * [Middle East](https://www.who.int/mega-menu/emergencies/emergencies/middle-east) * [Sudan](https://www.who.int/mega-menu/emergencies/emergencies/sudan) * [Ukraine](https://www.who.int/mega-menu/emergencies/emergencies/ukraine-emergency) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Latest](https://www.who.int/mega-menu/emergencies/news) * [Disease Outbreak News](https://www.who.int/mega-menu/emergencies/news/disease-outbreak-news) * [Situation reports](https://www.who.int/mega-menu/emergencies/news/situation-reports) * [Rapid risk assessments](https://www.who.int/mega-menu/emergencies/news/rapid-risk-assessment) * [Weekly Epidemiological Record](https://www.who.int/mega-menu/emergencies/news/weekly-epidemiological-record) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[WHO in emergencies](https://www.who.int/mega-menu/emergencies/who-in-emergencies) * [Surveillance](https://www.who.int/mega-menu/emergencies/who-in-emergencies/surveillance) * [Alert and response](https://www.who.int/mega-menu/emergencies/who-in-emergencies/alert-and-response) * [Operations](https://www.who.int/mega-menu/emergencies/who-in-emergencies/operations) * [Research](https://www.who.int/mega-menu/emergencies/who-in-emergencies/research-development) * [Funding](https://www.who.int/mega-menu/emergencies/who-in-emergencies/funding) * [Partners](https://www.who.int/mega-menu/emergencies/who-in-emergencies/partners) * [Health emergency appeals](https://www.who.int/mega-menu/emergencies/who-in-emergencies/health-emergency-appeal) * [International Health Regulations](https://www.who.int/mega-menu/emergencies/who-in-emergencies/international-health-regulations) * [Independent Oversight and Advisory Committee](https://www.who.int/mega-menu/emergencies/who-in-emergencies/independent-oversight-and-advisory-committee) * [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Data](https://www.who.int/mega-menu/data) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Data at WHO](https://www.who.int/mega-menu/data/data-who) * [Data hub](https://www.who.int/mega-menu/data/data-who/data-hub) * [Global Health Estimates](https://www.who.int/mega-menu/data/data-who/global-health-estimates) * [Health inequality](https://www.who.int/mega-menu/data/data-who/health-inequality) * [Global Health Observatory](https://www.who.int/mega-menu/data/data-who/global-health-obsevatory) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Dashboards](https://www.who.int/mega-menu/data/dashboards) * [Triple Billion Progress](https://www.who.int/mega-menu/data/dashboards/triple-billion-progress) * [Health Inequality Monitor](https://www.who.int/mega-menu/data/dashboards/health-inequality-monitor) * [Delivery for impact](https://www.who.int/mega-menu/data/dashboards/delivery-for-impact) * [COVID-19 dashboard](https://www.who.int/mega-menu/data/dashboards/covid-19-dashboard) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Data collection](https://www.who.int/mega-menu/data/data-collection) * [Classifications](https://www.who.int/mega-menu/data/data-collection/classifications) * [SCORE](https://www.who.int/mega-menu/data/data-collection/score) * [Surveys](https://www.who.int/mega-menu/data/data-collection/surveys) * [Civil registration and vital statistics](https://www.who.int/mega-menu/data/data-collection/civil-registration-and-vital-statistics) * [Routine health information systems](https://www.who.int/mega-menu/data/data-collection/routine-health-information-systems) * [Harmonized health facility assessment](https://www.who.int/mega-menu/data/data-collection/harmonized-health-facility-assessment) * [GIS centre for health](https://www.who.int/mega-menu/data/data-collection/gis-centre-for-health) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Reports](https://www.who.int/mega-menu/data/reports) * [World Health Statistics](https://www.who.int/mega-menu/data/reports/world-health-statistics) * [UHC global monitoring report](https://www.who.int/mega-menu/data/reports/uhc-global-monitoring-report) * [](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[About WHO](https://www.who.int/mega-menu/about-us) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[About WHO](https://www.who.int/mega-menu/about-us/about) * [Partnerships](https://www.who.int/mega-menu/about-us/about/partnerships-and-collaboration) * [Committees and advisory groups](https://www.who.int/mega-menu/about-us/about/expert-groups) * [Collaborating centres](https://www.who.int/mega-menu/about-us/about/collaborating-centres) * [Technical teams](https://www.who.int/mega-menu/about-us/about/teams) * [Organizational structure](https://www.who.int/mega-menu/about-us/about/structure) * [Who we are](https://www.who.int/mega-menu/about-us/about/who-we-are) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Our work](https://www.who.int/mega-menu/about-us/our-work) * [Activities](https://www.who.int/mega-menu/about-us/our-work/activities) * [Initiatives](https://www.who.int/mega-menu/about-us/our-work/initiatives) * [General Programme of Work](https://www.who.int/mega-menu/about-us/our-work/global-programme-of-work) * [WHO Academy](https://www.who.int/mega-menu/about-us/our-work/who-academy) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Funding](https://www.who.int/mega-menu/about-us/who-funding) * [Investment in WHO](https://www.who.int/mega-menu/about-us/who-funding/investment-case) * [WHO Foundation](https://www.who.int/mega-menu/about-us/who-funding/who-foundation) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Accountability](https://www.who.int/mega-menu/about-us/accountability) * [External audit](https://www.who.int/mega-menu/about-us/accountability/audit) * [Financial statements](https://www.who.int/mega-menu/about-us/accountability/financial-statements) * [Internal audit and investigations ](https://www.who.int/mega-menu/about-us/accountability/internal-audit-and-investigations) * [Programme Budget](https://www.who.int/mega-menu/about-us/accountability/budget) * [Results reports](https://www.who.int/mega-menu/about-us/accountability/results-report) * [ ](https://www.who.int/news/item/10-11-2026-who-updates-global-catalogue-for-interpreting-tuberculosis-drug-resistance-mutations)[Governance](https://www.who.int/mega-menu/about-us/governance) * [Governing bodies](https://www.who.int/mega-menu/about-us/governance/governing-bodies-website) * [World Health Assembly](https://www.who.int/mega-menu/about-us/governance/wha) * [Executive Board](https://www.who.int/mega-menu/about-us/governance/eb) * [Member States Portal](https://www.who.int/mega-menu/about-us/governance/member-states-portal) * [HomeWorld Health Organization](https://www.who.int/) * [Health Topics](https://www.who.int/mega-menu/health-topics) * [Countries](https://www.who.int/mega-menu/countries) * [Newsroom](https://www.who.int/news-room) * [Emergencies](https://www.who.int/mega-menu/emergencies) * [Data](https://www.who.int/mega-menu/data) * [About WHO](https://www.who.int/mega-menu/about-us) * [HomeWorld Health Organization](https://www.who.int/) * [Health Topics](https://www.who.int/mega-menu/health-topics) * [All topics](https://www.who.int/health-topics/) * [All topics](https://www.who.int/health-topics/) * [A](https://www.who.int/health-topics/#A) * [B](https://www.who.int/health-topics/#B) * [C](https://www.who.int/health-topics/#C) * [D](https://www.who.int/health-topics/#D) * [E](https://www.who.int/health-topics/#E) * [F](https://www.who.int/health-topics/#F) * [G](https://www.who.int/health-topics/#G) * [H](https://www.who.int/health-topics/#H) * [I](https://www.who.int/health-topics/#I) * [J](https://www.who.int/health-topics/#J) * [K](https://www.who.int/health-topics/#K) * [L](https://www.who.int/health-topics/#L) * [M](https://www.who.int/health-topics/#M) * [N](https://www.who.int/health-topics/#N) * [O](https://www.who.int/health-topics/#O) * [P](https://www.who.int/health-topics/#P) * [Q](https://www.who.int/health-topics/#Q) * [R](https://www.who.int/health-topics/#R) * [S](https://www.who.int/health-topics/#S) * [T](https://www.who.int/health-topics/#T) * [U](https://www.who.int/health-topics/#U) * [V](https://www.who.int/health-topics/#V) * [W](https://www.who.int/health-topics/#W) * [X](https://www.who.int/health-topics/#X) * [Y](https://www.who.int/health-topics/#Y) * [Z](https://www.who.int/health-topics/#Z) * [Resourc
## Related Clinical Research

- [SARS-CoV-2 antibody landscape after multiple Omicron-era vaccinations and infections](https://medichelpline.com/clinical-feed/medrxiv-23-sars-cov-2-antibody-landscape-following-multiple-vaccinations-and-infections.md)
- [Distinct Maturation-Associated Neutrophil Transcriptional Programs in COVID-19 Versus Tuberculosis](https://medichelpline.com/clinical-feed/biorxiv-2-covid-19-and-active-tuberculosis-exhibit-distinct-maturation-associated.md)
- [Near-point-of-care CRP and SAA meet WHO target product profile for TB screening](https://medichelpline.com/clinical-feed/medrxiv-4-near-point-of-care-c-reactive-protein-and-serum-amyloid-a-test-met-who-target.md)
- [WHO and ILO launch framework to track universal social protection for people with TB](https://medichelpline.com/clinical-feed/who-0-3-new-who-ilo-framework-to-track-progress-towards-universal-social-protection.md)
- [Self-reported tuberculosis prevalence and vulnerability factors in six rural Indian districts](https://medichelpline.com/clinical-feed/plos-one-16-self-reported-prevalence-of-tuberculosis-and-selected-associated-vulnerability.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.